Your SlideShare is downloading. ×
Unlocking Data for Profitable Clinical Development - Staffan Gestrelius & Jerker Ringstrom, Capish
Upcoming SlideShare
Loading in...5
×

Thanks for flagging this SlideShare!

Oops! An error has occurred.

×
Saving this for later? Get the SlideShare app to save on your phone or tablet. Read anywhere, anytime – even offline.
Text the download link to your phone
Standard text messaging rates apply

Unlocking Data for Profitable Clinical Development - Staffan Gestrelius & Jerker Ringstrom, Capish

359
views

Published on

Staffan Gestrelius and Jerker Ringstrom of Capish, a solution provider at the marcus evans Evolution Summit 2012 in North America and Evolution Summit 2012 in Europe, on unlocking the data of clinical …

Staffan Gestrelius and Jerker Ringstrom of Capish, a solution provider at the marcus evans Evolution Summit 2012 in North America and Evolution Summit 2012 in Europe, on unlocking the data of clinical trials for more profitable clinical development.
Interview with: Staffan Gestrelius, President and Chief Executive Officer & Jerker Ringstrom, Head of Business Development, Capish

Published in: Business, Education

0 Comments
0 Likes
Statistics
Notes
  • Be the first to comment

  • Be the first to like this

No Downloads
Views
Total Views
359
On Slideshare
0
From Embeds
0
Number of Embeds
0
Actions
Shares
0
Downloads
0
Comments
0
Likes
0
Embeds 0
No embeds

Report content
Flagged as inappropriate Flag as inappropriate
Flag as inappropriate

Select your reason for flagging this presentation as inappropriate.

Cancel
No notes for slide

Transcript

  • 1. Unlocking Data for Profitable Clinical Development Staffan Gestrelius: Scientists need to then all of a sudden you have to focus probe and analyze data the way the on the patient and what genetic financial sector does. To make better patterns or biomarkers he reacts to, this decisions and learn more about their will be an important turning point in compounds and patients, they must drug development. unlock data throughout the study and not just at the end. This will become even more important with personalized medicine. How can clinical data become a Knowledge knowledge asset? directly impacts Jerker Ringstrom: One of the most important words in this space is profitability “knowledge”. To turn data into a knowledge asset, it must be put into perspective. Scientists need constant feedback when deciding whether to Can it help scientists be more continue with a program or to make innovative? How? amendments. Jerker Ringstrom: Scientists can get If you look at a clinical trial protocol, it new ideas for indications by better usually mirrors the situation of the analyzing data. More drugs today are study six to eight months before it being used in new formulations and for ended. This means there was time to new indications, but finding these newInterview with: Staffan Gestrelius, make valuable changes to the design indications is proving to be challenging.President and Chief Executive and improve the quality of the trial.Officer & Jerker Ringstrom, Head of How is this approach moreBusiness Development, Capish How could this enhance safety? profitable? Staffan Gestrelius: If you have a system Staffan Gestrelius: This will be aScientists must unlock and analyze data that continuously watches over patients knowledge game. It will become crucialthroughout the clinical trial, according and gives you access to graphs and to know everything about a specificto Staffan Gestrelius, President and statistics, you can keep track of adverse drug. This approach is more profitableChief Executive Officer and Jerker events and drug associated adverse because people are not willing to pay forRingstrom, Head of Business effects. The earlier this is done, the a drug that only has a 50 per centDevelopment, Capish. From a solution better. chance of curing them. The reason whyprovider company at the marcus evans many companies are troubled today isEvolution Summit 2012, in North Jerker Ringstrom: This also helps because they do not have good enoughAmerica and the Evolution Summit pharmaceutical companies be patient treatments.2012 in Europe, Gestrelius and centric. When you develop a new drug,Ringstrom discuss how knowledge you need to come up with a diagnostic Knowledge directly impacts profitability.directly impacts the profitability of tool. The patient plays a more central Pharmaceutical companies should focusclinical development. role than before, as the diagnosis will be more on knowledge than on showing the torch through the darkness. I that the drug is not dangerous, simplyWhat role can Business Intelligence emphasize darkness, because when you to get it approved by the FDA. This willtools play in clinical development? focus on means and standard deviations not be enough.
  • 2. For more information please send an email to info@marcusevanscy.com or visit The Pharma Network - the event websites below: marcus evans Summits group delivers peer-to-peer information Evolution Summit 2012 - North America: www.evolutionsummit.com on strategic matters, professional trends and breakthrough Evolution Summit 2012 - Europe: www.evolution-summit.com innovations. Contact Please note that the Summit is a Sarin Kouyoumdjian-Gurunlian, Press Manager, marcus evans, Summits closed business event and the Division number of participants strictly Tel: + 357 22 849 313 limited. Email: press@marcusevanscy.com All rights reserved. The above content may be republished or reproduced. Kindly inform us by sending an email to press@marcusevanscy.comAbout CapishCapish is a Swedish Knowledge Management Service Organisation founded in 2001. We can give non-data literate expertsimmediate access to all clinical and non-clinical information through easy-to-use web-based interactive graphical interfaces forsearching and also interactive statistical tools for analyses. Capish will shortly be available for prospective trials.www.capishknowledge.comAbout marcus evans Summitsmarcus evans Summits are high level business forums for the world’s leading decision-makers to meet, learn and discussstrategies and solutions. Held at exclusive locations around the world, these events provide attendees with a unique opportunity toindividually tailor their schedules of keynote presentations, think tanks, seminars and one-on-one business meetings.For more information, please visit: www.marcusevans.comUpcoming EventsDiscovery Summit (Europe) - www.discovery-summit.comDiscovery Summit (North America) - www.thediscoverysummit.comEvolution Summit (Europe) - www.evolution-summit.comEvolution Summit (North America) - www.evolutionsummit.comTo view the web version of this interview please click here:www.pharmaceuticalseries.com/StaffanGestreliusJerkerRingstrom

×